Clarithromycin in the treatment of Legionella pneumophila pneumonia associated with multiorgan failure in a previously healthy patient

Clinical Drug Investigation

Volumn 25, Issue 7, 2005, Pages 485-490

  Gallelli, L ^a   Gioffre V ^a   Vero, G ^a   Gallelli, A ^a   Roccia, F ^a   Naty, S ^a   Pelaia, G ^a   Capano, A ^a   Loiacono, A ^a   De Sarro, G ^a   Maselli, R ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; CEFTAZIDIME; CEFTRIAXONE; CLARITHROMYCIN; LEVOFLOXACIN; MACROLIDE; METHYLPREDNISOLONE; NYSTATIN; SULTAMICILLIN; TEICOPLANIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PNEUMONIA; BACTERIAL VIRULENCE; BACTERIUM CULTURE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DISEASE ASSOCIATION; DYSPNEA; FACIAL NERVE PARALYSIS; FEMALE; FEVER; FIBEROPTIC BRONCHOSCOPY; GRAM NEGATIVE INFECTION; HUMAN; LEGIONELLA PNEUMOPHILA; LUNG LAVAGE; LYMPHOCYTOPENIA; MULTIPLE ORGAN FAILURE; OTITIS MEDIA; PRIORITY JOURNAL; SERODIAGNOSIS; THORAX PAIN; THORAX RADIOGRAPHY; THROMBOCYTOPENIA;

EID: 22544486285     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200525070-00008     Document Type: Article

References (33)

1. Eliopoulous GM, Reiszner E, Ferraro MJ, et al. Comparative in vitro activity of A-56268 (TE-031), a new macrolide. J Antimicrob Chemother 1988; 21: 671-5
2. Ianaro A, Ialenti A, Maffia P, et al. Anti-inflammatory activity of macrolide antibiotics. J Pharmacol Exp Toxicol 2000; 292: 156-63
3. Tagaya E, Tamaoki J, Kondo M, et al. Effect of a short course of clarithromycin therapy on sputum production in patients with chronic airway obstruction. Chest 2002; 122: 213-8
4. Yanagihara K, Tomono K, Kuroki M, et al. Intrapulmonary concentrations of inflammatory cytokines in a mouse model of chronic respiratory infection caused by Pseudomonas aeruginosa. Clin Exp Immunol 2000; 122: 67-71
5. Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med 1995; 333: 1618-24
6. File TM. Community-acquired pneumonia. Lancet. 2003; 362: 1991-2001
7. Bates JH, Campbell GD, Barron AL, et al. Microbial etiology of acute pneumonia in hospitalized patients. Chest 1992; 101: 1005-12
8. Torres A, Serra-Batlles J, Ferrer A, et al. Severe community-acquired pneumonia: epidemiology and prognostic factors. Am Rev Respir Dis 1991; 144: 312-8
9. Falcò V, Fernandez de Sevilla T, Alegre J, et al. Legionella pneumophila. A cause of severe community-acquired pneumonia. Chest 1991; 100: 1007-11.
10. Potgieter PD, Hammond JMJ. Etiology and diagnosis of pneumonia requiring ICU admission. Chest 1992; 101: 199-203
11. Heath CH, Grove DI, Looke DFM. Delay in appropriate therapy of Legionella pneumonia associated with increased mortality. Eur J Clin Microbiol Infect Dis 1996; 15: 286-90
12. Roig J, Rello J. Legionnaires' disease: a rational approach to therapy. J Antimicrob Chemother 2003; 51: 1119-22
13. Roig J, Rello J, Yu V L. Legionnaires' disease: a guide to diagnosis and therapy. J Respir Dis 2002; 23: 229-34
14. Chang FY, Yu VL. Legionella infections. In: Braunwald E, Fauci AS, Kasper DL, et al. editors. Harrison's Principles of Internal Medicine. 15th ed. McGraw-Hill, NY 2001: 945-9
15. Stout JE, Yu VL. Current concepts: legionellosis. N Engl J Med 1997; 337: 682-7
16. Woodhead M. Community-acquired pneumonia in Europe: causative pathogens and resistance patterns. Eur Respir J 2002; 20 Suppl. 36: 20s-7s
17. Lowry PW, Tompkins LS. Nosocomial legionellosis: a review of pulmonary and extrapulmonary syndromes. Am J Infect Control 1993; 21: 21-7
18. Edelstein PH, Meyer RD, Finegold SM. Long-term follow-up of two patients with pulmonary cavitation caused by Legionella pneumophila. Am Rev Respir Dis 1981; 124: 90-3
19. Muder RR, Yu VL. Infection due to Legionella species other than L. pneumophila. Clin Infect Dis 2002; 35: 990-8
20. Tkatch LS, Kusne S, Irish WD, et al. Epidemiology of legionella pneumonia and factors associated with legionella-related mortality at a tertiary care center. Clin Infect Dis 1998; 27: 1479-86
21. Schindel C, Siepmann U, Han S, et al. Persistent legionella infection in a patient after bone marrow transplantation. J Clin Microbiol 2000; 38: 4294-5
22. Shah PB, Giudice JC, Griesback R Jr, et al. The newer guidelines for the management of community-acquired pneumonia. J Am Osteopath Assoc 2004; 104: 521-6
23. Gleason PP, Meehan TP, Fine JM, et al. Associations between initial antimicrobial therapy and medical outcomes for hospitalised elderly patients with pneumonia. Arch Intern Med 1999; 159: 1562-72
24. Mundy LM, Oldach D, Auwaerter PG, et al. Implications for macrolide treatment in community-acquired pneumonia. Hopkins CAP Team. Chest 1998; 113: 1201-6
25. Sabria M, Campins M. Legionnaires' disease: update on epide miology and management options. Am J Respir Med 2003; 2: 235-43
26. Yu VL. Legionella pneumophyla (Legionnaires' disease). In Mandel GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett's principles and practice of infectious diseases. Churchill Livingstone, New York (NY) 1995: 2087-97
27. Mandell LA, Bartlett JG, Dowell SF, et al. Infectious Diseases Society of America. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003; 37: 1405-33
28. Plouffe JF, Breiman RF, Fields BS, et al. Azithromycin in the treatment of Legionella pneumonia requiring hospitalisation. Clin Infect Dis 2003; 37: 1475-80
29. Rodvold KA, Gotfried MH, Danziger LH, et al. Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers. Antimicrob Agents Chemother 1997; 41: 1399-402
30. Conte Jr JE, Golden J, Duncan S, et al. Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects. Antimicrob Agents Chemother 1996; 40: 1617-22
31. Capitano B, Mattoes HM, Shore E, et al. Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults. Chest 2004; 125: 965-73
32. Seidel MG, Kastner U, Minkov M, et al. IVIG treatment of adenovirus infection-associated macrophage activation syndrome in a two-year-old boy: case report and review of the literature. Pediatr Hematol Oncol 2003; 20: 445-51
33. Garrison MW, Anderson DE, Campbell DM, et al. Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model. Antimicrob Agents Chemother 1996; 40: 2859-64